Didem Melis Oztas

専門分野: Cardiothoracic surgeon
17年の経験
話します:
English
勤務先: トルコ, イスタンブール, Biruni University Hospital
2019年の第19回全国血管・血管内外科会議にて、口頭発表で第2位を受賞しました。
Didem Melis Oztas医師は、イスタンブールのビルニ大学病院の心臓血管外科医です。小児心臓外科および先天性心疾患を専門としています。Oztas医師は、心臓血管幹細胞に関する研究で国家賞を受賞しました。
- ファロー四徴症および心房中隔欠損症の専門的な手術を行います。
- 心室中隔欠損症を含む複雑な小児心疾患を治療します。
- 小児弁置換術および心臓弁形成術の専門家です。
- TEMOS認定を受けた15の手術室を持つ大学病院で勤務しています。

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Dr. Didem Melis Oztas is a cardiovascular surgeon at Biruni University Hospital in Istanbul. She treats pediatric cardiac conditions and heart defects in children. Dr. Oztas received a national award for her research on stem cells in cardiovascular tissue.

Specialization and Surgical Focus

The surgeon treats congenital heart diseases in pediatric patients. She performs procedures to correct structural issues present from birth. Her surgical practice includes:

Atrial and ventricular septal defect surgery
Tetralogy of Fallot repair
Pediatric aortic and mitral valve replacement
Plastic surgery for cardiac valves
Coronary angioplasty and angiography

Dr. Oztas also treats conditions such as atelocardia — a congenital heart defect where part of the heart is missing. She uses CT coronary angiography to plan interventions. This imaging technique creates detailed 3D pictures of the heart vessels.

Professional Experience

2023–Present — Cardiovascular Surgeon, Biruni University Hospital
2021–2023 — Cardiovascular Surgeon, Istanbul Training and Research Hospital
2019–2021 — Cardiovascular Surgeon, Bağcılar Training and Research Hospital
2013–2019 — Physician, Istanbul University Istanbul Faculty of Medicine

Education and Training

2018 — Specialization in Cardiovascular Surgery, Istanbul University Istanbul Faculty of Medicine
2013 — Medical Degree, Istanbul University Istanbul Faculty of Medicine

Research and Recognition

Dr. Oztas researches regenerative medicine in cardiology. Her work investigates stem cell levels in diabetic cardiovascular tissue. Additionally, she earned 2nd prize for an oral paper at the 19th National Vascular and Endovascular Surgery Congress in 2019. The study investigated the effect of erythropoietin on stem cell levels in diabetic rats.